Association between Mitofusin 2 Gene Polymorphisms and Late-Onset Alzheimer's Disease in the Korean Population.
- Author:
Young Jong KIM
1
;
Jin Kyung PARK
;
Won Sub KANG
;
Su Kang KIM
;
Changsu HAN
;
Hae Ri NA
;
Hae Jeong PARK
;
Jong Woo KIM
;
Young Youl KIM
;
Moon Ho PARK
;
Jong Woo PAIK
Author Information
- Publication Type:Original Article
- Keywords: MFN2; Mitochondrial fusion; Alzheimer's disease
- MeSH: Alzheimer Disease*; Brain; Clinical Coding; Female; Gene Frequency; Genotype; Humans; Male; Mitochondrial Dynamics; Optic Atrophy, Autosomal Dominant; Polymorphism, Genetic; Polymorphism, Single Nucleotide
- From:Psychiatry Investigation 2017;14(1):81-85
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVE: Mitochondrial dysfunction is a prominent and early feature of Alzheimer's disease (AD). The morphologic changes observed in the AD brain could be caused by a failure of mitochondrial fusion mechanisms. The aim of this study was to investigate whether genetic polymorphisms of two genes involved in mitochondrial fusion mechanisms, optic atrophy 1 (OPA1) and mitofusin 2 (MFN2), were associated with AD in the Korean population by analyzing genotypes and allele frequencies. METHODS: One coding single nucleotide polymorphism (SNP) in the MFN2, rs1042837, and two coding SNPs in the OPA1, rs7624750 and rs9851685, were compared between 165 patients with AD (83 men and 82 women, mean age 72.3±4.41) and 186 healthy control subjects (82 men and 104 women, mean age 76.5±5.98). RESULTS: Among these three SNPs, rs1042837 showed statistically significant differences in allele frequency, and genotype frequency in the co-dominant 1 model and in the dominant model. CONCLUSION: These results suggest that the rs1042837 polymorphism in MFN2 may be involved in the pathogenesis of AD.
